BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 12624522)

  • 1. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Hübel K; Engert A
    Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The resurgence of granulocyte transfusions.
    Harris DJ
    J Infus Nurs; 2009; 32(6):323-9. PubMed ID: 19918141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.
    Drewniak A; Boelens JJ; Vrielink H; Tool AT; Bruin MC; van den Heuvel-Eibrink M; Ball L; van de Wetering MD; Roos D; Kuijpers TW
    Haematologica; 2008 Jul; 93(7):1058-67. PubMed ID: 18508794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte transfusion: revisited.
    Briones MA; Josephson CD; Hillyer CD
    Curr Hematol Rep; 2003 Nov; 2(6):522-7. PubMed ID: 14561398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte transfusion therapy.
    Marfin AA; Price TH
    J Intensive Care Med; 2015 Feb; 30(2):79-88. PubMed ID: 23920161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte transfusion therapy.
    Price TH
    J Clin Apher; 2006 Apr; 21(1):65-71. PubMed ID: 16619227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Granulocyte transfusion].
    Reikvam H; Blom US; Kristoffersen E; Liseth K; Bruserud O; Hervig T
    Tidsskr Nor Laegeforen; 2009 Feb; 129(5):416-9. PubMed ID: 19247402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM
    W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusion therapy.
    Strauss RG
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1159-66. PubMed ID: 7860442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of G-CSF for granulocyte transfusion therapy.
    Hübel K; Dale DC; Engert A; Liles WC
    Cytokines Cell Mol Ther; 2000 Jun; 6(2):89-95. PubMed ID: 11108574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
    Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
    Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of the chemotherapy for malignant brain tumors--treatment with granulocyte transfusion for refractory infection due to agranulocytosis].
    Kokunai T; Kuwamura K; Yamada T
    No Shinkei Geka; 1982 Sep; 10(9):933-8. PubMed ID: 7177328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth factors in oncology: effectiveness and prospects].
    Ottmann OG; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.
    Ofran Y; Avivi I; Oliven A; Oren I; Zuckerman T; Bonstein L; Rowe JM; Dann EJ
    Vox Sang; 2007 Nov; 93(4):363-9. PubMed ID: 18070282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson SP; Marks DI
    Bone Marrow Transplant; 2004 Nov; 34(10):839-46. PubMed ID: 15273712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of granulocyte transfusions in neutropenic patients.
    Bishton M; Chopra R
    Br J Haematol; 2004 Dec; 127(5):501-8. PubMed ID: 15566353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.